Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Feb 12, 2001
Clinical News
VirtualPhenotype: Marketed
...for anti-HIV drugs. Data were presented at the Retroviruses and Opportunistic Infections conference in Chicago.
Vircolab
...
Read More
BioCentury
|
Aug 14, 2000
Company News
Virco Group other research news
...Virco's
VircoLab
subsidiary (Baltimore, Md.) received a $400,000 contract from the Centers for Disease Control and...
Read More
BioCentury
|
Feb 7, 2000
Clinical News
Antivirogram: Marketed
...San Francisco. Antivirogram is marketed in the U.S. at a cost of $800 per assay.
Vircolab
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Feb 12, 2001
Clinical News
VirtualPhenotype: Marketed
...for anti-HIV drugs. Data were presented at the Retroviruses and Opportunistic Infections conference in Chicago.
Vircolab
...
Read More
BioCentury
|
Aug 14, 2000
Company News
Virco Group other research news
...Virco's
VircoLab
subsidiary (Baltimore, Md.) received a $400,000 contract from the Centers for Disease Control and...
Read More
BioCentury
|
Feb 7, 2000
Clinical News
Antivirogram: Marketed
...San Francisco. Antivirogram is marketed in the U.S. at a cost of $800 per assay.
Vircolab
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page